Luca Quagliata
Private Equity Investor bei Xgen Venture Sgr SpA
Profil
Dr Luca Quagliata joined XGEN as Venture Partner in 2023.
Luca is VP and Global Head of Medical Affairs for the Genetic Science Group at Thermo Fisher Scientific.
Before joining Thermo Fisher, Luca worked as Senior Director and Team Leader of the Molecular Diagnostics Division at the Institute of Pathology, University Hospital Basel, Switzerland.
Luca is trained in Medical Biotechnology (Naples, Italy), holds a Ph.D.
in Vascular Medicine (Heidelberg, Germany), a Certificate of Achievement (COA) in Genetics (Harvard, Boston), was a visiting fellow at the NCI-NIH (Bethesda, USA), and is a Board-Certified Specialist in Medical Affairs (BCMAS).
Aktive Positionen von Luca Quagliata
| Unternehmen | Position | Beginn |
|---|---|---|
Xgen Venture Sgr SpA
 Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Private Equity Investor | 01.01.2023 |
Ausbildung von Luca Quagliata
| Heidelberg University (Ohio) | Doctorate Degree |
| Università degli Studi di Napoli Federico II | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Finance |
